advertisement
Abstract #127580 Published in IGR 25-3
Evaluation of the effectiveness of Ahmed's valve implantation adding mitomicin C in patients with refractory glaucoma after one year of follow-up
Teherán O; Parra C; Ramos E; Ochoa M; Escobar WArchivos de la Sociedad Espanola de Oftalmologia 2025; 100: 521-527
PURPOSE: To evaluate the effectiveness and safety of mitomycin C (MMC) use when implanting Ahmed valve in patients with refractory glaucoma. METHODS: Cohort study involving 34 patients divided into two groups of 17 patients each: Group 1 (MMC use) and Group 2 (no MMC use), with a one-year follow-up. Complete success was defined as intraocular pressure (IOP) between 6-18 mmHg without the use of antiglaucoma medications; qualified success referred to the same IOP range but associated with antiglaucoma medications, while failure was characterized by IOP outside this range, severe complications or reintervention. RESULTS: The overall success rate in Group 1 was 88.2%, and in Group 2, 94.2%. There was an average reduction in IOP of 18.0-± 11.5 mmHg in Group 1 and 11.3 ± 5.0 mmHg in Group 2. The hypertensive phase occurred in 17.6% of the participants in the first group and the second, 70.6%. CONCLUSIONS: The use of MMC decreases the hypertensive phase observed in Ahmed valve implant surgery, thereby achieving better IOP control.
Specialsit in Ophthalmology, High specialty in glaucoma, Professor of glaucoma, Universidad del Sinu Elias Bechara Zainum, Cartagena, Colombia. Electronic address: oscarteheran@hotmail.com.
Full article